Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

ClinicalTrials.gov ID: NCT00144430

Public ClinicalTrials.gov record NCT00144430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Pentostatin For the Treatment of High Risk or Refractory Chronic GVHD in Children

Study identification

NCT ID
NCT00144430
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Other
Enrollment
60 participants

Conditions and interventions

Interventions

  • Pentostatin Drug

Drug

Eligibility (public fields only)

Age range
1 Month to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2003
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Feb 2, 2009

2004 – 2008

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Loma Linda University Medical Center Loma Linda California 92350
Pediatric Medical Center for Northern California Oakland California 94609
Nemour's Children's Clinic Jacksonville Florida 32007
University of Miami Miami Florida 33136
All Children's Health System St. Petersburg Florida 33701
Children's Healthcare of Atlanta Atlanta Georgia 30322
Children's Memorial Hospital Chicago Illinois 60614
Riley Hospital for Children Indianapolis Indiana 46202
LSUHSC New Orleans Louisiana 70112
John's Hopkins Baltimore Maryland 21287
University of Michigan Ann Arbor Michigan 48109
DeVos Children's Hospital Grand Rapids Michigan 49503
Children's Mercy Hospital Kansas City Missouri 64108
St. Louis University St Louis Missouri 63104
Hackensack University Medical Center Hackensack New Jersey 07602
Columbia Presbyterian Medical Center New York New York 10032-3702
New York Medical College Valhalla New York 10595
Rainbow Babies and Children's Cleveland Ohio 44106
Columbus Children's Hospital Columbus Ohio 43205
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Victor Aquino, MD Dallas Texas 75390
Cook Children's Medical Center Fort Worth Texas 76104
Southwest Texas Methodist Hospital San Antonio Texas 78229
University of Utah Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00144430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2009 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00144430 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →